Advertisement

Picture Swiss Biotech Association MSC Global Village 2025 Basel 650x100px
Document › Details

Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA.

Organisations Organisation Agilent Technologies Inc. (NYSE: A)
  Organisation 2 Roche (Group)
Products Product analytical instrument
  Product 2 diagnostics (medical/biological)
Persons Person Ballmer, Allison (Agilent 202101– SVP Strategy + Corporate Development joined 5/18 before Roche + Biocartis)
  Person 2 McMullen, Mike (Agilent 201409– COO + designated CEO for 3/15 before SVP + President Chemical Analysis Group)
     


Agilent Technologies Inc. (NYSE: A) is pleased to announce Allison Ballmer has been named the company’s new senior vice president of Strategy and Corporate Development, reporting to Agilent President and CEO Mike McMullen.

Ballmer will lead the corporate-development team in identifying, developing, and evaluating merger-and-acquisition plans globally, as well as program management of integrations. She also will lead enterprise strategy while collaborating with Agilent businesses groups to drive critical growth initiatives across the company. Ballmer will serve as a key member of the executive staff and as an adviser to the CEO to help shape the company’s overall strategic direction.

"With nearly 20 years in the biotech industry — the last two being at Agilent — Allison brings a wealth of experience to this role. Her depth of knowledge in global business and marketing will serve Agilent well as we look to continue our Build-and-Buy growth strategy," McMullen said.

Prior to joining Agilent in May 2018 as vice president of Business Development and Strategy for the company’s Diagnostics and Genomics business, Ballmer spent nearly a decade of her career at Switzerland-based Roche, a multinational health-care company that operates pharmaceutical and diagnostics divisions.

She currently holds the role of lead director of the board of directors at Mission Bio, a California venture-backed company focused on genomics and precision medicine.

Ballmer holds a Bachelor of Science in mechanical engineering from Virginia Polytechnic Institute and State University.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.


Media Contact

Tom Beermann
Agilent Technologies
+1 408 553 2914
tom.beermannt@agilent.com

Investor Contact

Ankur Dhingra
Agilent Technologies
+1 408 345 8948
ankur_dhingra@agilent.com

   
Record changed: 2023-06-05

Advertisement

Picture Swiss Biotech Association MSC Swiss Biotech Days 2025 Basel 650x200px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x300px




» top